Please join us for our complimentary webinar "Pharmacogenetics: Considerations in Benefits Plan and Disability Management" on Thursday, June 25, 2020.
Interest in the field of pharmacogenetics continues to grow among patients, plan sponsors and industry stakeholders. However, as is the case with many emerging therapeutic areas, there continues to be a significant degree of confusion among plan sponsors surrounding its role, place in therapy, and value to their benefits plans and members. This session will aim to provide an overview of:
Thursday, June 25, 2020
9:00-10:00 AM Eastern
Please click here to register.
Clinical Pharmacist & Director of Plan Analytics
Scott is a Clinical Pharmacist and Director of Plan Analytics at Cubic Health, a health plan management and analytics company based in Toronto. Cubic works with large, self-insured plan sponsors including single- and multi-employer plans, Health & Welfare Trusts and Employee Life and Health Trusts in both the public and private sectors.
In his role at Cubic, Scott works with plan sponsors using objective, data-driven analytics to optimize the efficiency and sustainability of their benefit plan designs. In particular, Scott focuses predominantly in the areas of Predictive Analytics and integrated drug, extended health and disability analytics. His work involves collaboration with Cubic's Clinical and Data Science teams and has helped to contribute to Cubic's 15 consecutive years of Federal Research & Development accreditation for the analytics and clinical infrastructure that continues to evolve to address more complex challenges.
Prior to joining the Cubic team, Scott worked in a community pharmacy focused on specialty compounding, and has extensive experience in the fields of chronic pain management and pediatrics. He has a Bachelor of Science degree in Biochemistry from Western University as well as his Bachelor of Science in Pharmacy and Doctor of Pharmacy degrees both from the University of Waterloo.